Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vycor MedicalVYCO Days Payable is 95.05 as of Mar. 2026, which is 78% below its 10-year median of 428.59. The stock has 2 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Vycor Medical ranks better than 73.55% on this metric.
The historical rank and industry rank for Vycor Medical's Days Payable or its related term are showing as below:
VYCO'
s Days Payable Range Over the Past 10 Years
Min: 128.28 Med: 428.59 Max: 586.21
Current: 128.28
During the past 13 years, Vycor Medical's highest Days Payable was 586.21. The lowest was 128.28. And the median was 428.59.
VYCO's Days Payable is ranked better than 73.55% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs VYCO: 128.28
Vycor Medical's Days Payable
declined
from Mar. 2025 (185.46) to Mar. 2026 (95.05).
It may suggest that Vycor Medicalaccelerated paying its suppliers.
Vycor Medical Days Payable Related Terms
Vycor Medical Days Payable Historical Data
* Premium members only.
The historical data trend for Vycor Medical's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VYCO vs AEMD, VTAK, ALURD: Days Payable Comparison
For the Medical Devices subindustry, Vycor Medical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vycor Medical Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vycor Medical's Days Payable distribution charts can be found below:
* The bar in red indicates where Vycor Medical's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Vycor Medical's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vycor Medical (VYCO) has a Days Payable of 95.05 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vycor Medical and its competitors. This is 78% below median its historical median of 428.59. Over the past decade, Vycor Medical's Days Payable has ranged from 128.28 to 586.21. According to the industry distribution chart, Vycor Medical ranks #210 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 26.4%.
Is Vycor Medical's Days Payable too high?
Vycor Medical's current Days Payable of 95.05 is 78% below median its 10-year median of 428.59. Over the past 10 years, this metric has ranged from a low of 128.28 to a high of 586.21. The Medical Devices & Instruments industry median Days Payable is 67.97. Vycor Medical's value of 95.05 is 39.8% above this industry median. Based on the distribution chart, Vycor Medical ranks #210 out of 794 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Vycor Medical's Days Payable compare to AEMD and VTAK?
According to the Medical Devices & Instruments industry distribution chart, Vycor Medical ranks #210 out of 794 companies for Days Payable. This puts Vycor Medical in the upper half of its industry. The industry median Days Payable is 67.97. Vycor Medical's value of 95.05 is 39.8% above this benchmark. Historically, Vycor Medical's own Days Payable has ranged from 128.28 to 586.21 over the past decade. While the company's 10-year median is 428.59 vs. the industry median of 67.97, Vycor Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vycor Medical's current Days Payable of 95.05 is 39.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vycor Medical and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vycor Medical's current Days Payable is 95.05, which is 78% below median its own 10-year median of 428.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vycor Medical stock overvalued right now?
Based on GuruFocus' analysis, Vycor Medical (VYCO) is currently considered Possible Value Trap. The stock's GF Value™ is $0.12, compared to a current price of $0.07 — trading 42.5% below its estimated fair value. The current Days Payable is 95.05, which is 78% below median its 10-year median of 428.59 and 39.8% above the Medical Devices & Instruments industry median of 67.97. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Vycor Medical (VYCO), the current Days Payable is 95.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vycor Medical Inc provides the medical community with superior surgical and therapeutic solutions and operates two distinct business units within the medical device industry. Vycor Medical designs, develops and markets medical devices for use in neurosurgery. NovaVision provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage such as that caused by a stroke. The company operates in two segments, Vycor Medical and NovaVision, with the majority of the revenue been derived from Vycor Medical segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VYCO has been successfully added to your 
